Tag:
Ronacalaret
Latest Headlines
Latest Headlines
GSK ends NPS's osteoporosis drug study
Bad news for NPS Pharmaceuticals: the company announced late Thursday that its partner GlaxoSmithKline would abandon a Phase II study of Ronacalaret, an osteoporosis drug. According to SEC filings
